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The novel coronavirus (SARS-CoV-2) that is responsible for coro-
navirus disease (COVID-19) has emerged as a global crisis.1
According to the Johns Hopkins University information site, as of
4 June 2020, over 6.29 million cases have been confirmed, and
about 380 000 deaths due to COVID-19 have been reported
world-wide. The severity of the disease has been reported to
range from mild to severe and eventually death.1 Paediatric
populations seem to comprise only a small proportion of total
affected individuals and are less likely than adults to be severely
affected by COVID-19. According to a recent epidemiological
study, 731 cases of COVID-19 were confirmed in children, of
whom more than 90% of patients were reported as asymptom-
atic or with mild to moderate symptoms.2 The clinical presenta-
tion of paediatric patients may differ from those of the adults and
can range from asymptomatic to acute upper respiratory tract
infection, gastrointestinal symptoms with shock or coagulation
dysfunction in severe cases.
To date, the exact pathophysiology of COVID-19 has not been
fully understood. However, emerging evidence suggests that a
vascular disease process may be a contributing factor in COVID-
19 pathogenesis.3 These findings indicate that direct viral-
mediated tissue damage and endothelial dysfunction in the set-
ting of an inflammatory state could be responsible for various
adverse outcomes.
A growing body of evidence from the UK, Europe and the
USA suggests that a number of paediatric patients could present
with fever, rash and shock with concomitant COVID-19 infection.
Recently, the Royal College of Paediatrics and Child Health
(UK) called this phenomenon paediatric inflammatory multi-
system syndrome temporally associated with SARS-CoV-2.4 Simi-
larly, the Centers for Disease Control and Prevention (USA)
termed this new presentation multisystem inflammatory syn-
drome in children (MIS-C). The exact underlying mechanisms
for this Kawasaki disease (KD)-like condition described in these
reports are not clear; but may be due to antibody or immune-
complex mediated effects in the setting of a post-infectious del-
ayed inflammatory process.
Herein, we describe an Iranian paediatric case of a concurrent
KD-like inflammatory syndrome and COVID-19 infection who
presented with shock.
Case Report
The patient was a 5-year-old girl who presented to paediatric
urgent care with 5 days of high-grade fever, vomiting, diarrhoea
and abdominal pain, which had been managed as an outpatient
as a viral infection. On the third day, she developed conjunctivi-
tis, blotchy rash and swelling of the hands. In the patient’s his-
tory, she had experienced upper respiratory symptoms over the
past 3 weeks that had improved with supportive care. At the ini-
tial clinical examination, the patient was ill and had generalised
erythematous skin rash, non-purulent bilateral conjunctivitis,
periorbital oedema and erythema, swelling and congestion of the
lips, mild swelling of the hands and moderate dehydration due to
vomiting and diarrhoea (Fig. 1). There was no evidence of
lymphadenopathy. Vital signs showed a temperature of 39.5C,
sinus tachycardia (165 beats/min), tachypnoea with normal
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breath sounds and an oxygen saturation of 98% and the blood
pressure was 75/55. Laboratory tests revealed lymphopaenia,
thrombocytopaenia, mildly elevated C-reactive protein (CRP) of
23 mg/L and erythrocyte sedimentation rate of 40 mm/h. She
had hyponatraemia (Na: 120 mEq/L) and elevated liver function
tests (Table 1). About 4 weeks before she was admitted to our
hospital, she had a positive history of exposure to her uncle who
was diagnosed with COVID-19. Owing to this history of expo-
sure, reverse transcriptase-polymerase chain reaction (RT-PCR)
and serology for SARS-CoV-2 were requested. The PCR was neg-
ative on two occasions; however, IgG for SARS-CoV-2 was posi-
tive (IgG: 10.3 times higher than reference standard; IgM: 0.2
times lower than reference standard; normal range was defined
as lower than 1.1 ratio) suggesting previous SARS-CoV-2
infection.
Prompt treatment with fluid resuscitation was initiated due to
the patient’s dehydration and low blood pressure. After vital
signs stabilised, the patient was evaluated for the possible diag-
nosis of KD. After establishing the diagnosis, standard treatment
for KD was started according to guidelines. She was treated with
a single dose of 2 g/kg intravenous immunoglobulin (IVIG) and
high-dose acetylsalicylic acid. The patient’s fever subsided after
the initiation of IVIG and she was without fever for about 24 h.
However, she developed high-grade fever again as well as hypo-
tension the next day. In serial laboratory tests, a markedly ele-
vated CRP level along with high procalcitonin and D-dimer were
observed (Table 1). There was evidence of shock and IVIG-
resistant KD. Inotropic management of the shock with epineph-
rine was started for the patient. According to advice from the
infectious diseases team, broad-spectrum antibiotics including
meropenem, vancomycin and ciprofloxacin was also adminis-
tered. After the shock resolved, a second dose of the IVIG was
initiated.
There were no significant findings on chest X-ray and the
echocardiogram was normal with no evidence of coronary artery
dilation. Our patient suffered from severe generalised abdominal
pain. On abdominal ultrasound scan, a fluid accumulation mea-
suring 33 × 34 × 14 mm was localised in the right lower
Fig 1 Skin rash, congestion of the lips and periorbital edema and ery-
thema. Image shared with parental permission.
Table 1 The laboratory data of the patient at baseline, during and after treatment
Laboratory tests Baseline† During hospitalisation‡ After treatment§
WBC, ×103/mm3 5.2 (Neu: 73%, Lym: 22%, Band: 3%, EO: 2%) 7.3 6.8
Hb, g/dL 11.5 9.7 8
Platelet count, mg/dL 93 187 294
ESR, mm/h 40 89 3
CRP, mg/L 23 103–220 6
D-Dimer, mg/L 2.5 1.2 0.3
Procalcitonine, ng/mL NA >100 1.4
AST, U/L 94 114 NA
ALT, U/L 111 76 NA
BUN, mg/dL 15 10.2 NA
Cr, mg/dL 0.8 0.21 NA
Na, mEq/L 120 127 NA
K, mEq/L 4.2 4.9 NA
Ca, mg/dL 8.6 NA NA
†Baseline laboratory values referred to outpatient results prior to admission.
‡Referred to 1 week after admission.
§Referred to 1 week post-discharge.
ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate;
Hb, haemoglobin; NA, not available; WBC, white blood cell.
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quadrant and a volume of 9 mL was reported. After 48 h, the
abdominal ultrasound scan was repeated in which a mild free
fluid collection was noted in the right paracolic area and pelvis.
During this time, the patient had orthostatic hypotension and
lower limb mottling while standing which was due to the pres-
ence of hyperinflammatory shock (Fig. 2). The symptoms and
fever were present for another 48 h. All of our patient’s signs and
symptoms began to improve on the third day of hospitalisation
after starting the second dose of IVIG and antibiotics. Antibiotic
treatment was continued for 1 week. The patient’s blood culture
and adenovirus-specific PCR tests were negative. At the time of
discharge, evidence of desquamation was observed on the
patient’s fingers. The patient was discharged with instructions to
take low dose aspirin (3 mg/kg daily) and plans for repeating her
follow-up echocardiogram 1 week after discharge.
Discussion
Since the first reported KD-like case of a 6-month-old female
infant who was concurrently diagnosed with COVID-19 in
Stanford Children’s Hospital in USA, a growing number of MIS-C
cases have been reported world-wide.5 Recently, an Italian
cohort of KD-like cases in Bergamo province, which experienced
the highest rate of COVID-19 infection and death in Italy,
reported a sudden surge of new cases of KD with an increased
incidence of nearly 30-fold over the past 5 years in that region.6
Although it has been hypothesised that a delayed immune
response to the virus might be contributing to the clinical feature
of MIS-C, the exact link between COVID-19 and MIS-C remains
unclear.
The role of respiratory viruses in the pathogenesis of KD is not
fully understood. According to previous studies, the most com-
mon viruses detected in KD patients were rhinovirus and entero-
virus.7 Although most of the reported COVID-19 cases among
children experienced mild symptoms, the potential to progress to
a more severe course such as with shock still exist and could lead
to permanent organ damage and mortality. The observed nega-
tive results of PCR in our patient along with high levels of serum
IgG could suggest that the virus had been cleared and the mani-
festations displayed in this patient may be due to delayed
immune-mediated phenomenon caused by COVID-19.8 How-
ever, limited data exist regarding the exact immunological mech-
anism of COVID-19 in predisposing individuals to
hyperinflammatory shock.
The patient presented in this study had severe symptoms
consistent with MIS-C and developed hyperinflammatory shock
during the admission but had a good response to standard treat-
ments. The high procalcitonin and CRP levels along with symp-
toms of shock in this patient suggest a serious and life-
threatening medical condition. With respect to her history of
contact with COVID-19, preceding upper respiratory tract
symptoms, positive IgG for SARS-CoV-2 and negative blood
culture; our patient’s symptoms appear to be related to COVID-
19. As more cases of concurrent COVID-19 and MIS-C have
been increasingly reported world-wide, whether this relation-
ship is causation or association is not yet fully elucidated. On
the epidemiological aspect of the current pandemic, the timing
between positive cases of COVID-19 and identification of new
cases of MIS-C in various locations, suggest that this phenome-
non may be partly contributed to by a delayed immune-
mediated process that is triggered by the SARS-CoV-2 infection.
This observation is supported by the fact that the majority of
reported cases were PCR negative for SARS-CoV-2, while serol-
ogy testing has been found to be positive in many cases.6 Nev-
ertheless, it is worth noting that although vasculitis is known to
be caused by coronavirus, it is too early to conclude that KD is
due to coronavirus.
Despite the growing number of reported cases, many ques-
tions remain unanswered about the new coronavirus such as
the treatment modalities, epidemiological, and clinical features
associated with COVID-19, especially in the paediatric popula-
tion. Early recognition and management of this novel phenome-
non is crucial in order to minimise potential complications of
this disease in the paediatric population. Further studies are
needed to increase our knowledge regarding MIS-C related to
COVID-19 pathogenesis.
Written informed consent for publication of this patient’s clini-
cal details and clinical images was obtained from the parents.
Fig 2 Lower limb mottling.
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